Pharmaceutical News

RSS

New drug candidate against HIV-infection

As a part of a research collaboration, scientists at the Sahlgrenska Academy at Gotenborg University, Sweden, have developed a new drug candidate against HIV-infection. The new substance, named alphaHGA, will be tested on patients this year.

30 Jun 2005

Old skin fungus drug has been found to be a possible cancer treatment

A drug that has been used for 40 years for the treatment of skin fungus has been found to be a possible cancer treatment, according to an international team of scientists. Leslie Wilson, professor of biochemistry and pharmacology at the University of California, Santa Barbara, said that the antifungal drug, griseofulvin, has been shown to inhibit the growth of cancer cells in his laboratory.

30 Jun 2005

Takeda Pharmaceuticals submits NDA for a new oral diabetes medication

Takeda Pharmaceuticals North America today announced that the company has submitted a New Drug Application (NDA) for a new oral medication that combines pioglitazone HCl and glimepiride, a sulfonylurea, to the United States Food and Drug Administration (FDA) for the treatment of type 2 diabetes.

30 Jun 2005

European women soon to have access to new breast cancer drug

European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.

29 Jun 2005

Keep taking Viagra, it won't make you blind!

In a review of its popular impotence treatment Viagra, Pfizer announced on Monday that it had found no evidence of increased risk of blindness among patients taking the erectile dysfunction drug.

28 Jun 2005

1.7 million will be anxious when Medicare coverage of anxiety drugs ceases

When the U.S. Government's new prescription drug benefit begins next year a category of drugs commonly used to treat anxiety, insomnia and seizures will not be included.

28 Jun 2005

Canada about to ban bulk sales of drugs to U.S.

According to some press reports Canada is about to announce a ban on bulk sales of drugs to the United States as a way of reining in Internet pharmacies that sell cheap medicine to Americans.

28 Jun 2005

New breast cancer drug not available to all who need it

Unless things change breast cancer patient Barbara Clark will probably have to sell her house to pay for an expensive drug called Herceptin.

28 Jun 2005

GlaxoSmithKline announces availability of Paxil CR to U.S. market

GlaxoSmithKline announced today the availability of Paxil CR (paroxetine hydrochloride controlled release) tablets in pharmacies across the United States. Other markets will follow shortly thereafter.

27 Jun 2005

Metabasis and Merck collaborate to develop new treatment for diabetes, hyperlipidemia and obesity

Metabasis Therapeutics and Merck announced today that they have formed a collaboration to research, develop and commercialize novel small molecule therapeutics with potential to treat several diseases, including type II diabetes, hyperlipidemia and obesity, by activation of an enzyme in the liver called AMP-activated Protein Kinase (AMPK).

27 Jun 2005

Nitromed heart drug designed for blacks wins U.S. approval

A new heart drug designed specifically for blacks has been approved by U.S. officials.

26 Jun 2005

Booze and autos don't mix - car crashes account for half of drinking injurie

Figures in a new survey, by the Canadian Institute for Health Information, show that car crashes account for more than half of severe alcohol-related injuries in Canada and nearly one-third of those hurt are under the age of 25.

23 Jun 2005

Safety warning on Internet drugs

Thousands of men in the UK buy “lifestyle drugs” such as erectile dysfunction medication, weight and hair loss products from websites and are oblivious to the fact that some (not all) of the websites belong to unscrupulous vendors.

21 Jun 2005

Canada first country to approve cannabis based painkiller

Canada has become the first country to approve a cannabis based painkiller for multiple sclerosis (MS) patients.

21 Jun 2005

Partnership to develop an AIDS vaccine using a promising new technology

GlaxoSmithKline Biologicals (GSK Biologicals) and the International AIDS Vaccine Initiative (IAVI) today announced a public-private partnership to develop an AIDS vaccine using a promising new technology.

21 Jun 2005

New cardiovascular drug derived from Dan Shen (Saliva miltiorrhiza)

Through a large number of clinical trials over the past 3 years, researchers from the CAS Shanghai Institute of Materia Medica (SIMM) have developed a new cardiovascular drug with a definite effective component extracted from Dan Shen (Saliva miltiorrhiza), a medicinal herb widely used in China.

21 Jun 2005

FDA severely limits access to cancer drug Iressa

After Food and Drug Administration (FDA) officials agreed with studies showing lung cancer drug, Iressa, did not help patients live longer, drug company AstraZeneca said it would severely limit access to its drug.

20 Jun 2005

FDA approves treatment for diarrhea caused by Cryptosporidium infection

The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.

19 Jun 2005

AstraZeneca announces U.S. labeling change to Iressa (gefitinib tablets)

AstraZeneca has announced that after discussions with the U.S. Food and Drug Administration (FDA), the company is making a labeling change to Iressa (gefitinib tablets).

19 Jun 2005